Clinical Pharmacology — MCQs
On this page
Antibiotic prophylaxis is indicated in which of the following procedures?
All of the following are physiological responses to smoking, EXCEPT:
A 60-year-old male presents with muscle pain, fatigue, and dark urine. His medical history includes stable angina, and his current medications are atenolol, atorvastatin, and aspirin. Urine dipstick is positive for blood, but microscopy reveals no RBCs. Serum creatinine kinase is significantly elevated. Which of the following medication additions is most likely to have precipitated this patient's condition?
For a patient undergoing anticoagulant therapy who requires unavoidable dental surgical treatment, what should the dental surgeon do?
A 40-year-old male patient presented with a characteristic facial rash, fever, arthralgia, and moderate chest pain. He reported using a certain drug for 3 months. On examination, there was no central nervous system involvement. Laboratory findings revealed normal urine routine microscopy and normal renal function tests. Antinuclear antibody (ANA) and anti-histone antibody titers were elevated. Which of the following mechanisms is most likely implicated in this condition?
Which of the following medications is an inhibitor of angiotensin-converting enzyme (ACE)?
All the following are complications of streptokinase, except?
Which of the following statements about Histamine is true?
What is the concentration of potassium in Ringer Lactate solution?
Which of the following is given to prevent methotrexate toxicity?
Clinical Pharmacology Indian Medical PG Practice Questions and MCQs
Question 21: Antibiotic prophylaxis is indicated in which of the following procedures?
- A. Cardiac catheterisation
- B. Prostatectomy
- C. Cystoscopy
- D. Dental procedures (Correct Answer)
Explanation: Explanation: The primary goal of antibiotic prophylaxis in clinical practice is to prevent **Infective Endocarditis (IE)** in high-risk patients or to prevent surgical site infections. [1] **1. Why Dental Procedures are correct:** Dental procedures involving manipulation of gingival tissue, the periapical region of teeth, or perforation of the oral mucosa (e.g., extractions, scaling) are notorious for causing transient bacteremia, typically with *Viridans group streptococci*. According to current AHA/IDSA guidelines, prophylaxis is indicated for these procedures **only in high-risk patients** (e.g., prosthetic heart valves, previous IE, or certain congenital heart diseases). **2. Why the other options are incorrect:** * **Cardiac Catheterization (A):** This is a clean vascular procedure. The risk of bacteremia is extremely low (<1%), and routine prophylaxis is not recommended. * **Prostatectomy (B) & Cystoscopy (C):** While these are urological procedures, routine IE prophylaxis is no longer recommended by modern guidelines unless there is an active infection. If the patient has a documented UTI, the infection should be treated before the procedure; otherwise, the risk of IE from sterile urologic manipulation is negligible. **High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice:** Oral **Amoxicillin (2g)** given 30–60 minutes before the procedure. * **If Penicillin allergic:** Use **Clindamycin (600mg)**, Azithromycin, or Cephalexin. * **High-Risk Conditions requiring IE prophylaxis:** 1. Prosthetic heart valves (including TAVI). 2. Prior history of Infective Endocarditis. 3. Unrepaired cyanotic congenital heart disease. 4. Cardiac transplant recipients with valve regurgitation. [1] * **Prophylaxis is NOT indicated for:** Routine anesthetic injections, X-rays, shedding of primary teeth, or simple GI endoscopies.
Question 22: All of the following are physiological responses to smoking, EXCEPT:
- A. Decreased HDL
- B. Increased hematocrit
- C. Increased heart rate and increased catecholamine release
- D. Decreased carboxyhemoglobin (Correct Answer)
Explanation: **Explanation:** The correct answer is **D. Decreased carboxyhemoglobin**. Smoking actually causes an **increase** in carboxyhemoglobin levels, not a decrease. **1. Why Option D is the Correct Answer:** Cigarette smoke contains **carbon monoxide (CO)**, which has an affinity for hemoglobin that is 200–250 times greater than that of oxygen [1]. When inhaled, CO binds to hemoglobin to form **carboxyhemoglobin (COHb)**. This shifts the oxygen-dissociation curve to the left, reducing oxygen delivery to tissues [1], [2]. Chronic smokers typically have COHb levels between 5–10%, compared to <1% in non-smokers. **2. Why the other options are incorrect (Physiological responses to smoking):** * **A. Decreased HDL:** Smoking modifies lipid metabolism, leading to a pro-atherogenic profile characterized by decreased High-Density Lipoprotein (HDL) and increased LDL and triglycerides. * **B. Increased hematocrit:** To compensate for the chronic tissue hypoxia caused by elevated carboxyhemoglobin, the kidneys increase **erythropoietin** production. This results in secondary polycythemia (increased hematocrit). * **C. Increased heart rate and catecholamine release:** Nicotine stimulates the sympathetic nervous system and the adrenal medulla, leading to the release of **epinephrine and norepinephrine**. This acutely increases heart rate, blood pressure, and myocardial contractility. **High-Yield Clinical Pearls for NEET-PG:** * **Smoking and Surgery:** Patients are advised to stop smoking at least **6–8 weeks** before surgery to reduce pulmonary complications and improve wound healing. * **Drug Interactions:** Smoking **induces CYP1A2**. This can lead to decreased serum levels of drugs like **Theophylline** and **Clozapine**. * **Buerger’s Disease (Thromboangiitis Obliterans):** A non-atherosclerotic inflammatory disease strongly associated with heavy smoking; the primary treatment is absolute smoking cessation.
Question 23: A 60-year-old male presents with muscle pain, fatigue, and dark urine. His medical history includes stable angina, and his current medications are atenolol, atorvastatin, and aspirin. Urine dipstick is positive for blood, but microscopy reveals no RBCs. Serum creatinine kinase is significantly elevated. Which of the following medication additions is most likely to have precipitated this patient's condition?
- A. Erythromycin (Correct Answer)
- B. Rifampin
- C. Griseofulvin
- D. Amikacin
Explanation: ### Explanation **Correct Answer: A. Erythromycin** **Mechanism & Concept:** The patient is presenting with **Statin-induced Rhabdomyolysis**, characterized by the triad of muscle pain, elevated Creatine Kinase (CK), and myoglobinuria (positive dipstick for blood but negative microscopy for RBCs). [1] Atorvastatin is metabolized by the **Cytochrome P450 3A4 (CYP3A4)** enzyme system. **Erythromycin** is a potent **CYP3A4 inhibitor**. When added to a stable statin regimen, erythromycin inhibits the metabolism of atorvastatin, leading to toxic plasma levels of the drug [1]. This increases the risk of skeletal muscle toxicity, ranging from mild myalgia to life-threatening rhabdomyolysis and acute kidney injury. **Analysis of Incorrect Options:** * **B. Rifampin:** This is a potent **CYP450 inducer**. It would increase the metabolism of atorvastatin, thereby *decreasing* its plasma concentration and efficacy, rather than causing toxicity. * **C. Griseofulvin:** This is also a **CYP450 inducer** (though less potent than Rifampin). It would not precipitate statin toxicity. * **D. Amikacin:** An aminoglycoside known for nephrotoxicity and ototoxicity, but it does not interact with the CYP3A4 system or increase the risk of statin-induced myopathy. **High-Yield Clinical Pearls for NEET-PG:** * **Common CYP3A4 Inhibitors (The "Statin-Killers"):** Macrolides (Erythromycin, Clarithromycin), Azole antifungals (Ketoconazole), Protease inhibitors (Ritonavir), and Grapefruit juice. * **Safe Alternatives:** If a macrolide is necessary, **Azithromycin** is preferred as it does not significantly inhibit CYP3A4. * **Statin Metabolism:** Atorvastatin, Lovastatin, and Simvastatin are CYP3A4 substrates [1]. **Pravastatin** and **Rosuvastatin** are not significantly metabolized by CYP3A4 and carry a lower risk of these specific drug interactions. [1] * **Diagnostic Clue:** "Heme positive, RBC negative" urine always suggests Myoglobinuria (Rhabdomyolysis) or Hemoglobinuria (Hemolysis).
Question 24: For a patient undergoing anticoagulant therapy who requires unavoidable dental surgical treatment, what should the dental surgeon do?
- A. Not undertake the procedure until the anticoagulant therapy is completed.
- B. Reduce the dosage of anticoagulant and proceed with the procedure.
- C. Adjust the dosage before and after the dental visit.
- D. Consult the patient's physician for a joint decision. (Correct Answer)
Explanation: ### Explanation **1. Why the Correct Answer is Right:** The management of a patient on anticoagulants (like Warfarin or DOACs) requires a delicate balance between the **risk of thromboembolism** (if the drug is stopped) and the **risk of post-operative hemorrhage** (if the drug is continued) [1]. Because the underlying indication for anticoagulation (e.g., prosthetic heart valves, atrial fibrillation, or recent DVT) varies in severity, the dental surgeon cannot unilaterally alter the regimen. A **multidisciplinary approach** involving the patient’s physician/cardiologist is essential to assess the patient's specific thromboembolic risk profile and determine if bridging therapy or temporary cessation is required. **2. Why the Other Options are Wrong:** * **Option A:** Delaying treatment until therapy is completed is often impossible, as many patients are on lifelong anticoagulation. Delaying urgent dental surgery can lead to systemic infection or worsening pain. * **Option B & C:** Adjusting or reducing the dosage independently by the dentist is dangerous. For example, sub-therapeutic levels of warfarin in a patient with a mechanical heart valve can lead to fatal valve thrombosis [1]. Any dose modification must be supervised by the prescribing physician. **3. High-Yield Clinical Pearls for NEET-PG:** * **INR Guidelines:** For most minor dental procedures (extractions, scaling), if the **INR is < 3.5**, the procedure can usually proceed without stopping Warfarin, using local hemostatic agents (e.g., tranexamic acid mouthwash, oxidized cellulose) [1]. * **Bridging Therapy:** High-risk patients (e.g., those with mechanical valves) may require "bridging" with Heparin (LMWH) if Warfarin must be stopped [1]. * **DOACs:** For Direct Oral Anticoagulants (Rivaroxaban, Apixaban), the timing of the procedure is usually planned just before the next dose is due to ensure the lowest plasma concentration.
Question 25: A 40-year-old male patient presented with a characteristic facial rash, fever, arthralgia, and moderate chest pain. He reported using a certain drug for 3 months. On examination, there was no central nervous system involvement. Laboratory findings revealed normal urine routine microscopy and normal renal function tests. Antinuclear antibody (ANA) and anti-histone antibody titers were elevated. Which of the following mechanisms is most likely implicated in this condition?
- A. Drug-induced hypersensitivity reaction
- B. Autoimmune reaction mediated by cytotoxic T cells
- C. Immune complex deposition in blood vessels
- D. Formation of autoantibodies against nuclear antigens due to drug interaction (Correct Answer)
Explanation: ### Explanation The clinical presentation of a facial rash, fever, arthralgia, and pleuritic chest pain (suggestive of serositis) in a patient taking a long-term medication points toward **Drug-Induced Lupus Erythematosus (DILE)**. **1. Why the Correct Answer is Right:** DILE is characterized by the **formation of autoantibodies against nuclear antigens** (specifically histones) triggered by certain drugs [1]. Unlike systemic lupus erythematosus (SLE), DILE typically spares the CNS and kidneys (explaining the normal urine microscopy and renal function). The hallmark laboratory finding is the presence of **Anti-histone antibodies** (positive in >95% of cases) and a positive **ANA**. The mechanism involves the drug or its metabolites acting as haptens or altering the epigenetic methylation of T cells, leading to the loss of self-tolerance and the production of autoantibodies. **2. Why Other Options are Wrong:** * **Option A:** Drug-induced hypersensitivity (like DRESS syndrome) usually presents with eosinophilia, lymphadenopathy, and organ dysfunction (liver/kidney), rather than specific anti-histone antibodies. * **Option B:** While T cells are involved in the loss of tolerance, the primary diagnostic and pathogenic feature of DILE is the B-cell mediated production of autoantibodies. * **Option C:** Immune complex deposition (Type III hypersensitivity) is the mechanism for *Serum Sickness* or the systemic manifestations of *SLE*, but the question specifically asks for the mechanism implicated in the *formation* of the condition described (autoantibody production). **3. High-Yield Facts for NEET-PG:** * **Common Culprits (SHIPP):** **S**ulfonamides, **H**ydralazine (highest risk), **I**soniazid, **P**rocainamide (highest risk), **P**henytoin. * **Key Markers:** Anti-histone antibodies (Most specific for DILE); Anti-dsDNA is usually **negative** (unlike SLE). * **Genetic Predisposition:** More common in **slow acetylators** (due to the role of the N-acetyltransferase enzyme in drug metabolism). * **Management:** Symptoms usually resolve within weeks of **discontinuing the offending drug**.
Question 26: Which of the following medications is an inhibitor of angiotensin-converting enzyme (ACE)?
- A. hydralazine
- B. enalapril (Correct Answer)
- C. spironolactone
- D. metoprolol
Explanation: **Explanation:** **Enalapril** is the correct answer as it belongs to the **Angiotensin-Converting Enzyme (ACE) Inhibitors** class. These drugs work by inhibiting the enzyme responsible for converting Angiotensin I to Angiotensin II (a potent vasoconstrictor) and by preventing the breakdown of bradykinin [1]. This results in systemic vasodilation and decreased aldosterone secretion, making them first-line agents for hypertension, heart failure, and diabetic nephropathy [2]. **Analysis of Incorrect Options:** * **A. Hydralazine:** A direct-acting **arteriolar vasodilator**. It is primarily used in hypertensive emergencies in pregnancy or in combination with nitrates for heart failure in specific populations. * **C. Spironolactone:** A **potassium-sparing diuretic** that acts as a competitive antagonist at the mineralocorticoid (aldosterone) receptor in the distal renal tubules. * **D. Metoprolol:** A **selective Beta-1 adrenergic blocker** (cardioselective). It reduces blood pressure and heart rate by decreasing cardiac output and renin release. **High-Yield Clinical Pearls for NEET-PG:** * **Suffix Recognition:** ACE inhibitors typically end in **"-pril"** (e.g., Lisinopril, Ramipril) [1]. * **Side Effects:** The most common side effect is a **dry cough** (due to increased bradykinin levels) [3]. A more severe but rare side effect is **angioedema** [1]. * **Teratogenicity:** ACE inhibitors are strictly **contraindicated in pregnancy** as they cause fetal renal dysgenesis (teratogenic). * **Metabolism:** Most ACE inhibitors are **prodrugs** (e.g., Enalapril is converted to Enalaprilat), except for **Lisinopril and Captopril**, which are active drugs.
Question 27: All the following are complications of streptokinase, except?
- A. Joint pain (Correct Answer)
- B. Intracranial bleed
- C. Anaphylaxis
- D. Hypotension
Explanation: Streptokinase is a first-generation fibrinolytic agent derived from *Beta-hemolytic Streptococci* [1]. Understanding its mechanism and side-effect profile is crucial for NEET-PG. **Why Joint Pain is the Correct Answer:** Joint pain (arthralgia) is **not** a recognized or typical complication of streptokinase therapy. While streptokinase is highly immunogenic, its allergic manifestations usually present as skin rashes, urticaria, or systemic anaphylaxis rather than isolated joint involvement. **Analysis of Incorrect Options:** * **Intracranial Bleed:** This is the most feared complication of all thrombolytic agents. By activating plasminogen to plasmin systemically, streptokinase creates a "lytic state," significantly increasing the risk of hemorrhagic stroke [1], [3]. * **Anaphylaxis:** Since streptokinase is a bacterial protein (non-human source), it is highly antigenic [1], [3]. Patients may develop Type I hypersensitivity reactions, ranging from mild rashes to fatal anaphylactic shock. This is why it cannot be readministered within 6–12 months due to high antistreptococcal antibody titers. * **Hypotension:** This is a common side effect unique to streptokinase (not seen with Alteplase). It is often infusion-rate dependent and is thought to be mediated by the release of bradykinin. **High-Yield Clinical Pearls for NEET-PG:** * **Mechanism:** It is a non-specific plasminogen activator [1], [2]; it binds to plasminogen to form an active complex that converts free plasminogen into plasmin. * **Half-life:** Approximately 20 minutes. * **Contraindication:** Previous streptococcal infection or prior streptokinase use (due to neutralizing antibodies) [3]. * **Management of Bleeding:** If life-threatening bleeding occurs, the antidote is **Epsilon-aminocaproic acid** or **Tranexamic acid**.
Question 28: Which of the following statements about Histamine is true?
- A. Is found in Mast cells
- B. Increases gastric acid secretion
- C. Related to arousal and blood pressure
- D. All of the above (Correct Answer)
Explanation: Histamine is a biogenic amine that acts as a critical mediator in inflammation, gastric physiology, and neurotransmission [1]. The correct answer is **D (All of the above)** because histamine exerts diverse physiological effects through four distinct G-protein coupled receptors ($H_1$ to $H_4$). **Breakdown of Options:** * **Option A (Mast Cells):** Histamine is primarily synthesized and stored in the granules of **mast cells** and **basophils** [1]. Upon IgE-mediated sensitization and subsequent antigen exposure, these cells degranulate, releasing histamine into the systemic circulation (Type I Hypersensitivity). * **Option B (Gastric Acid):** Histamine is released from **Enterochromaffin-like (ECL) cells** in the stomach [1]. It acts on **$H_2$ receptors** located on gastric parietal cells, stimulating the proton pump to increase gastric acid secretion [1]. This is the physiological basis for using $H_2$ blockers (e.g., Famotidine) in peptic ulcer disease. * **Option C (Arousal and BP):** In the CNS, histaminergic neurons in the **tuberomammillary nucleus** of the hypothalamus regulate wakefulness and arousal (explaining why first-generation antihistamines cause sedation) [1]. Peripherally, histamine causes vasodilation via $H_1$ and $H_2$ receptors, leading to a **decrease in blood pressure** and contributing to the pathophysiology of anaphylactic shock. **High-Yield Clinical Pearls for NEET-PG:** * **Triple Response of Lewis:** Characterized by Red spot (vasodilation), Wheal (exudation), and Flare (axonal reflex). * **Receptor Specificity:** $H_1$ (Allergy/Smooth muscle), $H_2$ (Gastric acid), $H_3$ (Presynaptic/CNS), $H_4$ (Chemotaxis) [1]. * **Drug of Choice:** Adrenaline (1:1000 IM) is the physiological antagonist of histamine and the drug of choice for anaphylaxis.
Question 29: What is the concentration of potassium in Ringer Lactate solution?
- A. 1 mEq/L
- B. 4 mEq/L (Correct Answer)
- C. 2 mEq/L
- D. 6 mEq/L
Explanation: ### Explanation Ringer’s Lactate (RL), also known as Hartmann's solution, is a balanced crystalloid solution designed to closely mimic the electrolyte composition of human plasma [1]. It is the fluid of choice for resuscitation in trauma, burns, and intraoperative fluid replacement. **Why Option B is Correct:** The concentration of **Potassium (K+) in Ringer’s Lactate is 4 mEq/L**. This concentration is intentionally set to match the normal physiological range of potassium in human extracellular fluid (3.5–5.0 mEq/L). This makes RL "iso-kalemic," reducing the risk of significant electrolyte shifts during large-volume resuscitation compared to Normal Saline (0.9% NaCl), which contains no potassium. **Analysis of Incorrect Options:** * **Option A (1 mEq/L) & C (2 mEq/L):** These concentrations are too low to maintain physiological homeostasis and do not represent any standard balanced crystalloid. * **Option D (6 mEq/L):** This exceeds the normal plasma range. Administering a fluid with 6 mEq/L of potassium could potentially worsen hyperkalemia, especially in patients with renal compromise. **High-Yield Clinical Pearls for NEET-PG:** * **Composition of RL (per Liter):** Na+ (130–131 mEq), Cl- (109–111 mEq), Lactate (28–29 mEq), K+ (4 mEq), and Ca2+ (3 mEq) [1]. * **Osmolarity:** RL is slightly hypotonic (approx. 273 mOsm/L) compared to plasma (285–295 mOsm/L). * **Metabolism:** The lactate in RL is converted by the **liver** into bicarbonate, making it useful in treating metabolic acidosis. * **Contraindications:** Avoid RL in patients receiving blood transfusions (Calcium can cause clotting in the tubing if Citrate is present) and in patients with severe liver disease (inability to metabolize lactate).
Question 30: Which of the following is given to prevent methotrexate toxicity?
- A. MESNA
- B. Flumazenil
- C. Fomipezole
- D. Calcium leucovorin (Correct Answer)
Explanation: **Explanation:** **Correct Answer: D. Calcium leucovorin** **Mechanism of Action:** Methotrexate (MTX) is a cytotoxic antimetabolite that inhibits the enzyme **Dihydrofolate Reductase (DHFR)** [1]. This inhibition prevents the conversion of dihydrofolate to tetrahydrofolate (THF), the active form of folic acid required for DNA synthesis. **Calcium Leucovorin** (also known as Folinic Acid) is a reduced form of folate. It does not require DHFR for activation; instead, it bypasses the metabolic block created by MTX, providing a source of THF for healthy cells. This process is clinically termed **"Leucovorin Rescue,"** and it is administered 24 hours after high-dose MTX [1] to prevent bone marrow suppression and GI toxicity. **Analysis of Incorrect Options:** * **A. MESNA:** Used to prevent **hemorrhagic cystitis** caused by Acrolein, a toxic metabolite of Cyclophosphamide and Ifosfamide. * **B. Flumazenil:** A competitive benzodiazepine receptor antagonist used to reverse **Benzodiazepine overdose**. * **C. Fomepizole:** An inhibitor of alcohol dehydrogenase used as an antidote for **Methanol or Ethylene glycol poisoning** [2]. **High-Yield Clinical Pearls for NEET-PG:** * **Glucarpidase:** An alternative agent used in MTX toxicity (especially in renal failure) that directly degrades MTX into inactive metabolites. * **Vincristine Interaction:** Leucovorin should **not** be confused with the treatment for Vincristine overdose (which is managed with Hyaluronidase and warm compresses). * **Potentiation:** While Leucovorin "rescues" cells from MTX, it actually **potentiates** the activity of **5-Fluorouracil (5-FU)** by stabilizing its binding to thymidylate synthase.
Practice by Chapter
Pharmacokinetics and Pharmacodynamics
Practice Questions
Drug Metabolism and Excretion
Practice Questions
Adverse Drug Reactions and Interactions
Practice Questions
Therapeutic Drug Monitoring
Practice Questions
Pharmacogenomics and Precision Medicine
Practice Questions
Drug Development and Clinical Trials
Practice Questions
Rational Prescribing and Deprescribing
Practice Questions
Medication Adherence Strategies
Practice Questions
Special Populations (Pediatric, Geriatric, Pregnancy)
Practice Questions
Pharmacovigilance
Practice Questions
Want unlimited practice?
Get full access to all questions, explanations, and performance tracking.
Start For Free